Wadden TA - Search Results

1

The risk of cardiovascular complications with current obesity drugs.

Chao AM, Wadden TA, Berkowitz RI, Quigley K, Silvestry F. Chao AM, et al. Among authors: wadden ta. Expert Opin Drug Saf. 2020 Sep;19(9):1095-1104. doi: 10.1080/14740338.2020.1806234. Epub 2020 Sep 9. Expert Opin Drug Saf. 2020. PMID: 32750250 Free PMC article. Review.

2

Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective.

Wadden TA, Sternberg JA, Letizia KA, Stunkard AJ, Foster GD. Wadden TA, et al. Int J Obes. 1989;13 Suppl 2:39-46. Int J Obes. 1989. PMID: 2613427 Clinical Trial.

3

Psychosocial consequences of weight reduction: how much weight loss is enough?

Wadden TA, Steen SN, Wingate BJ, Foster GD. Wadden TA, et al. Am J Clin Nutr. 1996 Mar;63(3 Suppl):461S-465S. doi: 10.1093/ajcn/63.3.461. Am J Clin Nutr. 1996. PMID: 8615343 Review.

4

Binge eating disorder and the night-eating syndrome.

Stunkard A, Berkowitz R, Wadden T, Tanrikut C, Reiss E, Young L. Stunkard A, et al. Int J Obes Relat Metab Disord. 1996 Jan;20(1):1-6. Int J Obes Relat Metab Disord. 1996. PMID: 8788315

5

Exercise in the treatment of obesity: effects of four interventions on body composition, resting energy expenditure, appetite, and mood.

Wadden TA, Vogt RA, Andersen RE, Bartlett SJ, Foster GD, Kuehnel RH, Wilk J, Weinstock R, Buckenmeyer P, Berkowitz RI, Steen SN. Wadden TA, et al. J Consult Clin Psychol. 1997 Apr;65(2):269-77. doi: 10.1037//0022-006x.65.2.269. J Consult Clin Psychol. 1997. PMID: 9086690 Clinical Trial.

6

Lifestyle modification in the pharmacologic treatment of obesity: a pilot investigation of a potential primary care approach.

Wadden TA, Berkowitz RI, Vogt RA, Steen SN, Stunkard AJ, Foster GD. Wadden TA, et al. Obes Res. 1997 May;5(3):218-26. doi: 10.1002/j.1550-8528.1997.tb00296.x. Obes Res. 1997. PMID: 9192396 Free article. Clinical Trial.

7

The fen-phen finale: a study of weight loss and valvular heart disease.

Wadden TA, Berkowitz RI, Silvestry F, Vogt RA, St John Sutton MG, Stunkard AJ, Foster GD, Aber JL. Wadden TA, et al. Obes Res. 1998 Jul;6(4):278-84. doi: 10.1002/j.1550-8528.1998.tb00350.x. Obes Res. 1998. PMID: 9688104 Free article.

8

Valvular heart disease in fenfluramine- phentermine-treated patients: a comparison with control patients.

Wadden TA, Silvestry FE, Aber JL, Berkowitz RI, Foster GD, Sutton MG. Wadden TA, et al. Obes Res. 1999 May;7(3):309-10. doi: 10.1002/j.1550-8528.1999.tb00412.x. Obes Res. 1999. PMID: 10348504 Free article. No abstract available.

9

The treatment of obesity: what's new, what's recommended.

Sarwer DB, Wadden TA. Sarwer DB, et al. Among authors: wadden ta. J Womens Health Gend Based Med. 1999 May;8(4):483-93. doi: 10.1089/jwh.1.1999.8.483. J Womens Health Gend Based Med. 1999. PMID: 10839703 Review.

10

Behavioural treatment of the overweight patient.

Wadden TA, Sarwer DB, Berkowitz RI. Wadden TA, et al. Baillieres Best Pract Res Clin Endocrinol Metab. 1999 Apr;13(1):93-107. doi: 10.1053/beem.1999.0008. Baillieres Best Pract Res Clin Endocrinol Metab. 1999. PMID: 10932678 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

503 results

Search Page

Filters